Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arestin in Peri-Implantitis
NCT01517334Phase 3Completed
- Sponsor
- OraPharma
- Start
- May 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of minocycline in peri-implantitis (2 arms), sponsored by OraPharma. Primary endpoint: Change in mean Probing Depth of qualifying implant sites at Day 180. Started May 2012; status: completed.
02
Drugs
minocycline
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT01517334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01517334.